F. Gasior
Okay. Well, one, thanks for the question and good morning. Let's work the loan portfolio first. Probably the most significant development in the quarter, as far as the loan portfolio, was the reduction in the commercial and industrial lines and specifically with respect to health care. The various stimuli programs that were available to health care providers, whether it was PPP or Medicare advance payments, created an enormous amount of liquidity into that channel. So you saw in our disclosures, where $42 million worth of lines paid down, and those borrowers are, in fact, sitting on an additional $30 million of liquidity in deposit accounts here at the bank. So that was the most significant development. And if you say it's a factor of demand, I would just say they have an unexpected source of liquidity. And obviously, with that infusion of liquidity, they'll reduce their interest expense until such time as they have to repay the Medicare advances. But over time, that trend will reverse itself. So we do expect those lines to redraw over time. The liquidity dissipates or is repaid. That will have a couple of important factors. Certainly, that will be a material positive benefit to net interest margin. Annualized, the reduction in that portfolio cost us about $2.5 million in net interest income. So right off the bat, just recovering back to the original balances will be a material positive benefit in future quarters. It would also increase the loan loss reserve requirement probably by around $0.25 million. So that was one of the reasons why our provision in the second quarter was lower because the balance is simply paid down and you had no exposure to the portfolio at that point in time. So I would say on the -- this was the single biggest change there. We believe it to be temporary and transitory. The pace of recovery is an open question. Will there be more stimulus provided with future congressional action? It's certainly a possibility. Will hospital demand and provider demand shift from COVID care back to elective surgeries and more normal operations? Certainly, those trends have started. But in certain markets, they have been interrupted and they're back to COVID care. So I think it's going to be an uneven path there. But we haven't lost any customers. They just have a tremendous amount of liquidity they're working with now, which is certainly beneficial to their operations, a little bit less so to us, but we would expect it to recover over time. On the equipment finance side, it was just a slow quarter getting things closed. We've already had some higher activity now in the third quarter on the corporate side and on the governmental side. So we expect to have a stronger quarter here in the third quarter on corporate governmental. And we also have launched the middle market and are launching the small ticket this quarter. So we'll have some activity in that portfolio. Hard to say on the small ticket side. We're going to have a very careful rollout for the third quarter. Obviously, small businesses are taking some significant impacts due to COVID, and we're going to work our way through the opportunities we've seen. The intention was always to stay on the stronger side of the market, but we have to just kind of walk through that market and see what happens to us. We believe there is demand. We've been getting calls. The quality of that demand is what's an issue here. But we will probably see $2 million to $4 million worth of volume in the third quarter on small ticket; average transaction probably around $50,000 or so, could be bigger, could be smaller. But we're just going to take it very easy on that and have a very soft rollout, and we'll see what we see in the underwriting and what we see in demand. The middle market side, we launched that with a soft launch in the second quarter. We've got a good portfolio -- good pipeline going now. We have our initial staff set up in the middle market department, and they are actually starting their outreach next week as a matter of fact. So we feel pretty good about the demand there. A lot of that is replacement equipment. We're not seeing very much in the way of new investment right now, but there is a pretty good demand of replacement equipment. Some people are buying one piece of equipment and getting rid of 2 old ones because the new stuff is more productive. So we are feeling more optimistic about the middle market side. That part of the economy, especially in the replacement market, seems to be doing fairly well. On the real estate side, obviously, there's going to be demand for refinances, both internal and external. Our focus there is on the stronger part of the multifamily market, what we would consider are 50% risk-weighted loans. Yields have declined. We've seen them as low. We've seen some markets with under 3%. We're right around the 3.25%, 3.5% range for the very best credits. And we will continue to pursue those as the opportunities arise. We're not seeing that much in the way of purchases on the portfolio side. We are seeing more activity on the capital markets side for purchases. But really, those are transactions that have just taken a long time to come together because of the disruption in the second quarter. So net-net, we hope to get some improvement in yields and balances as health care recovers, that could be a slower process. Two, we'll see some improvements in balances for middle market, governmental and equipment finance. Corporate seems to be lagging, but it's [indiscernible] slower. And then three, real estate. I would say that we'll see some additional originations. I will also say we'll see some payoffs on that. So I would not expect a tremendous amount of growth out of real estate and it could, in fact, shrink. One thing we are not going to be doing is working through high-LTV cash-out refinances. If we can't get those transactions to go to capital markets, then we will simply pass on them and take the refinance -- take the payoff. Right now, you really, really have to think carefully about what could happen in multifamily. And we think that if people are trying to time the market at peak valuation and get every dollar out that they can, that's probably not a portfolio asset that we would prefer to book right now.